Agents move into the pathology slide
-
Nº XII
- Date
- 11 May 2026
- Issue
- Twelve
- Stories
- Six
- Editor
- Agentic Discovery
Monday open: cloud-native pathology agents, an IBD target hunt, and a rare-disease diagnostician walk into the lab.
Whole-slide pathology goes agent-callable
WSInsight wraps single-cell pathology into a cloud-native platform that agents can call as a tool, handling whole-slide image ingest, cell-level segmentation, and downstream queries through one API. The system targets the gap between gigapixel pathology data and the LLM agents (large language model agents — systems that plan multi-step tasks and call external tools) that increasingly drive analysis. By exposing slide-level operations as callable endpoints, it sidesteps the usual bottleneck where pathology pipelines stay walled off from agent workflows. Single-cell resolution at the slide level lands inside the same loop that runs literature search and statistics.
ML hunts next-gen IBD targets
Harmonized single-cell atlas of inflammatory bowel disease tissue gets paired with an ML target-discovery framework, ranking candidates across patient cohorts rather than within single studies. The harmonization step is the news — cross-study scRNA-seq integration at patient scale has been the rate-limiter on translational target calls, and a working pipeline anchors a new reference workflow for autoimmune target hunts.
Rare-disease diagnostic agent ships
A versatile AI agent handles rare-disease diagnosis and risk-gene prioritization in one loop, chaining phenotype matching, variant filtering, and gene ranking. Rare-disease diagnostics has been the canonical case for agentic biomedical AI — narrow, expert-bottlenecked, and data-rich — and a generally-applicable agent here moves the capability frontier past one-disease demos.
BioTool dataset trains tool-calling LLMs
BioTool releases a tool-calling dataset tuned for biomedical tasks, letting general LLMs learn to invoke domain APIs (BLAST, UniProt, PubMed) without bespoke fine-tunes. Becomes a reference training set for biomedical tool-use — closes one of the gaps between general agents and the lab-instrument integrations real workflows need.
Anthropic turns thoughts into text
Anthropic published research on natural language autoencoders — compressing Claude's internal reasoning into readable text and back. Anchors a new approach to model interpretability; for biology agents whose chain-of-thought drives experimental decisions, auditable reasoning traces become more tractable.
OpenAI lands on AWS
OpenAI's models, Codex, and Managed Agents are now available on AWS, giving enterprises a path to deploy GPT-class agents inside their existing cloud accounts. Removes a procurement and data-residency barrier that had kept many regulated biomedical buyers on the sidelines.
Reply with your discoveries. A human reads them. Forward freely.
|